-
Mashup Score: 4Human Organ Chips Shift Amodiaquine from Old Antimalarial to Promising COVID-19 Treatment - 3 year(s) ago
Human organ chip-based drug testing identified that the antimalarial drug amodiaquine has inhibiting effects against SARS-CoV-2.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 1Human Organ Chips Shift Amodiaquine from Old Antimalarial to Promising COVID-19 Treatment - 3 year(s) ago
Human organ chip-based drug testing identified that the antimalarial drug amodiaquine has inhibiting effects against SARS-CoV-2.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 2Human Organ Chips Shift Amodiaquine from Old Antimalarial to Promising COVID-19 Treatment - 3 year(s) ago
Human organ chip-based drug testing identified that the antimalarial drug amodiaquine has inhibiting effects against SARS-CoV-2.
Categories: Future of Medicine, Latest HeadlinesTweet-
Human #OrganChips Shift Antimalarial to Promising #COVID19 Treatment Human organ chip-based drug testing by @wyssinstitute, @IcahnMountSinai, & @UMmedschool identified the #antimalarialdrug amodiaquine has inhibiting effects against #SARSCoV2. Read more: https://t.co/2U88AivYvS https://t.co/pkGrONuLbo
-
-
Mashup Score: 2Event Page | Human Biology: An Exploration of Organs-on-Chips - 3 year(s) ago
An Exploration of Organs-on-Chips Virtual EventBiologic drugs comprise 40 percent of the current drug development pipeline. Existing in vitro and animal models are limited in their ability to evaluate the safety and efficacy of these drugs in humans. These limitations often result in development delays and increased costs.Organs-on-chips emulate human biology by providing a micro-engineered…
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 4Event Page | Human Biology: An Exploration of Organs-on-Chips - 3 year(s) ago
An Exploration of Organs-on-Chips Virtual EventBiologic drugs comprise 40 percent of the current drug development pipeline. Existing in vitro and animal models are limited in their ability to evaluate the safety and efficacy of these drugs in humans. These limitations often result in development delays and increased costs.Organs-on-chips emulate human biology by providing a micro-engineered…
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 2Event Page | Human Biology: An Exploration of Organs-on-Chips - 3 year(s) ago
An Exploration of Organs-on-Chips Virtual EventBiologic drugs comprise 40 percent of the current drug development pipeline. Existing in vitro and animal models are limited in their ability to evaluate the safety and efficacy of these drugs in humans. These limitations often result in development delays and increased costs.Organs-on-chips emulate human biology by providing a micro-engineered…
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 5Event Page | Human Biology: An Exploration of Organs-on-Chips - 3 year(s) ago
An Exploration of Organs-on-Chips Virtual EventBiologic drugs comprise 40 percent of the current drug development pipeline. Existing in vitro and animal models are limited in their ability to evaluate the safety and efficacy of these drugs in humans. These limitations often result in development delays and increased costs.Organs-on-chips emulate human biology by providing a micro-engineered…
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 3Event Page | Human Biology: An Exploration of Organs-on-Chips - 3 year(s) ago
An Exploration of Organs-on-Chips Virtual EventBiologic drugs comprise 40 percent of the current drug development pipeline. Existing in vitro and animal models are limited in their ability to evaluate the safety and efficacy of these drugs in humans. These limitations often result in development delays and increased costs.Organs-on-chips emulate human biology by providing a micro-engineered…
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 2Event Page | Human Biology: An Exploration of Organs-on-Chips - 3 year(s) ago
An Exploration of Organs-on-Chips Virtual EventBiologic drugs comprise 40 percent of the current drug development pipeline. Existing in vitro and animal models are limited in their ability to evaluate the safety and efficacy of these drugs in humans. These limitations often result in development delays and increased costs.Organs-on-chips emulate human biology by providing a micro-engineered…
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 12Event Page | Human Biology: An Exploration of Organs-on-Chips - 3 year(s) ago
An Exploration of Organs-on-Chips Virtual EventBiologic drugs comprise 40 percent of the current drug development pipeline. Existing in vitro and animal models are limited in their ability to evaluate the safety and efficacy of these drugs in humans. These limitations often result in development delays and increased costs.Organs-on-chips emulate human biology by providing a micro-engineered…
Categories: Future of Medicine, Latest HeadlinesTweet
Human Organ Chips Shift Amodiaquine from Old Antimalarial to Promising #COVID19 Treatment The antimalarial drug amodiaquine was found to inhibit #SARSCoV2 infection when tested in human organ chips. Learn more: https://t.co/PMQOKvVc2e #organonchip #organchips https://t.co/9uoRwOr9CR